Acumen Hypotension Prediction Index – EV1000 Clinical Platform vs Withings Scan Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Acumen Hypotension Prediction Index – EV1000 Clinical Platform
by Edwards Lifesciences
VS
Withings Scan Monitor
by Withings

AI Verdict

Tool A is a predictive clinical decision support system for acute care settings, specifically designed to anticipate and help manage intraoperative hypotension. In contrast, Tool B focuses on remote patient monitoring and personal health management, offering diagnostic capabilities for conditions like AFib and general vital sign tracking through consumer devices. While both utilize AI for cardiovascular health, their distinct operational contexts and primary objectives make them adjacent rather than direct competitors.

Choose Acumen Hypotension Prediction Index – EV1000 Clinical Platform if…

Choose Acumen Hypotension Prediction Index if your primary goal is real-time, proactive management and prevention of intraoperative hypotension or hemodynamic instability in critical care settings. This tool is ideal for anesthesiologists and critical care teams requiring advanced, continuous hemodynamic monitoring and predictive analytics to intervene before adverse events occur.

View Acumen Hypotension Prediction Index – EV1000 Clinical Platform →

Choose Withings Scan Monitor if…

Choose Withings Scan Monitor if you need a user-friendly, device-based solution for long-term remote patient monitoring, personal health management, and early detection of cardiac irregularities like AFib. This platform is well-suited for individuals and healthcare providers focused on continuous, non-invasive tracking of vital health metrics in a home or outpatient setting.

View Withings Scan Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform Withings Scan Monitor
Pricing Unknown Device purchase with optional subscription for enhanced features and clinical services.
Deployment On-premise (integrated with EV1000 clinical platform and HemoSphere advanced monitoring platform) Device-based (smart scale, smartwatch) with cloud synchronization and mobile application.
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Withings Scan Monitor

Withings Scan Monitor (Tool B) is designed for broad accessibility, integrating with smart scales and smartwatches, and leveraging a user-friendly mobile application for both personal and remote patient monitoring. Acumen HPI (Tool A) is integrated into a complex clinical platform, requiring specialized training for acute care professionals.

Clinical Value

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

Acumen HPI (Tool A) offers critical real-time prediction of hypotensive events up to 15 minutes in advance in high-stakes acute care settings, providing immediate, actionable insights to prevent severe complications. While Withings Scan Monitor (Tool B) provides valuable tools for chronic disease management and early detection of conditions like AFib, its clinical impact is generally less immediate and acute than Tool A's life-saving predictive capabilities.

Pricing & Value

Withings Scan Monitor

Withings Scan Monitor (Tool B) offers transparent pricing with a clear device purchase cost and an optional monthly subscription, making it accessible for individual users and smaller-scale remote patient monitoring programs. Acumen HPI (Tool A) requires contacting for pricing, indicating a complex, enterprise-level cost structure typically associated with capital equipment and institutional budgets.

Enterprise Readiness

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

Acumen HPI (Tool A) is explicitly designed for integration with the Edwards Lifesciences HemoSphere Advanced Monitoring Platform, signifying its readiness for seamless deployment within existing hospital infrastructure and acute care workflows. While Withings Scan Monitor (Tool B) is HIPAA and FDA compliant and offers professional support for RPM, its device-centric, consumer-oriented deployment model may require more extensive integration efforts for large-scale hospital enterprise systems beyond basic data feeds.

Innovation

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

Acumen HPI (Tool A) demonstrates significant innovation through its machine learning-based algorithm that provides real-time predictive analytics for acute, life-threatening hypotensive events, offering clinicians crucial insights into hemodynamic instability. Withings Scan Monitor (Tool B) is innovative in bringing advanced diagnostic capabilities like 6-lead ECG and vascular age assessment to accessible consumer devices, but Tool A's predictive capability for acute intervention stands out in its clinical impact.

Support & Docs

Tie

Edwards Lifesciences (Tool A) provides extensive clinical education, professional resources, and technical support typical of a major medical device company for its complex acute care platform. Withings (Tool B) offers comprehensive support for its Health Solutions partners, including dedicated customer success managers, technical integration assistance, and logistics management, alongside robust consumer support, making both highly capable in their respective domains.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform Withings Scan Monitor
Tool Name Acumen Hypotension Prediction Index u2013 EV1000 Clinical Platform Withings Scan Monitor
Company Edwards Lifesciences Withings
Primary Use Case / Description Uses machine learning to predict hypotensive events up to 15 minutes in advance, providing clinicians with insights into hemodynamic instability and potential causes to help reduce intraoperative hypotension. AI-powered tool integrated into smart scales and smartwatches, offering FDA-cleared ECG for AFib detection, heart rate, and other vital health metrics for both personal use and professional remote patient monitoring.
Core AI/Prediction Capability Machine learning-based algorithm predicts hypotension up to 15 minutes in advance; HPI Parameter (0-100 likelihood score). 6-lead ECG for Atrial Fibrillation (AFib) detection (Body Scan); Single-lead ECG for Atrial Fibrillation (AFib) detection (ScanWatch); irregular rhythm notifications.
Key Health Metrics / Insights Provided HPI Parameter, Smart Alerts for trending hypotension, Smart Trend screen, Relationship View screen (preload, afterload, contractility insights), Continuous hemodynamic monitoring. 6-lead ECG for AFib detection, single-lead ECG for AFib detection, heart rate, blood oxygen saturation (SpO2), Vascular Age assessment, Nerve Health Score, Segmental body composition analysis.
Target Medical Specialties Anesthesiology, Critical Care, Emergency Medicine Cardiology, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform and Withings Scan Monitor.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Tool A, the Acumen HPI, integrates with the Edwards Lifesciences HemoSphere platform for continuous hemodynamic monitoring, aiming to predict and help manage intraoperative hypotension. Tool B, the Withings Scan Monitor, is device-based with cloud synchronization and a mobile application, designed for remote patient monitoring to detect AFib and track general vital health metrics.
Tool A uses a machine learning-based algorithm to predict hypotensive events up to 15 minutes in advance, providing a likelihood score and smart alerts. Tool B offers FDA-cleared ECG capabilities for Atrial Fibrillation (AFib) detection, along with heart rate measurement and irregular rhythm notifications.
Tool A is primarily designed for Anesthesiology, Critical Care, and Emergency Medicine, focusing on patients at risk of hemodynamic instability. Tool B is suitable for Cardiology and Internal Medicine, supporting remote patient monitoring, particularly for AFib detection and broader health tracking.
Tool A provides an HPI Parameter (0-100 likelihood score), Smart Alerts for trending hypotension, a Smart Trend screen, and a Relationship View screen offering insights into preload, afterload, and contractility. Tool B offers 6-lead or single-lead ECG for AFib, heart rate, blood oxygen saturation, Vascular Age assessment, Nerve Health Score, and segmental body composition analysis.
Tool A acquires data through continuous hemodynamic monitoring using dedicated sensors, specifically the Acumen IQ cuff (non-invasive) or Acumen IQ sensor (minimally-invasive). Tool B collects data via device-based measurements from smart scales (Body Scan) and smartwatches (ScanWatch), with automatic synchronization via Wi-Fi and Bluetooth.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform or Withings Scan Monitor

Backers

Who funded each tool's parent company.

Withings Scan Monitor

AI Tool Finder
AI-powered search. Results may not be comprehensive.